Donald Zinn Email & Phone Number

Richland, MI, US

Dijon, Bourgogne, FR

Crossject has developed a needle-free auto-injector platform capable of delivery from the dermis to intramuscular for almost any liquid drug in 1/10th of a second. Human factor studies have demonstrated that naive users can successfully utilize the device greater than 99% of the time. The device has been selected by BARDA for the Strategic National.

New York, NY, US

GLG is the world’s leading platform connecting business to insights. Clients utilize GLG’s 650,000 member-experts to provide insights. Expertise includes business and scientific insights into the oncology, infectious disease, bone disease and biofilm spaces of the pharmaceutical, biotech and medical device industries.

Laupheim, Baden-Württemberg, DE

Head of US innovation, member of international innovation team spearheading global corporate expansion. Prepare and present company at various international pharmaceutical conferences (JP Morgan Healthcare Conference, Biotech Showcase, RESI, N.Y. Oncology Investors Conference) optimize presentations, script talking points, identify optimal strategic.

Grosse Pointe Farms, MI, US

Bozeman, Montana, US

Worldwide Business Development

An Apjohn Group discovery stage biotechnology company developing unique peptides for the treatment of osteoporosis, osteoarthritis, accelerated fracture healing, and other bone related diseases. Company turned its focus to Muscular Dystrophy an area in which I do not have expertise.President & CEO & Member of the Board of Directors, Vice President.

Allendale, MI, US

Four-year public university in Western Michigan providing a fully accredited liberal arts undergraduate and graduate education for more than 24,000 students.

Allendale, MI, US

Teach General Biology. Develop and implement teaching techniques that include interactive learning, laboratory techniques, laboratory equipment use and utilize audiovisual and computer technology in ways that enhance learning. Curriculum development and revision, committee membership, teaching symposium and textbook edit and selection. Advise students on.

Successful business accelerator with accomplished team comprised primarily of former Upjohn senior executives. Group launches life science companies focused on pharmaceuticals and medical devices. Executive In Residence (EIR) April 2007 - January 2008Responsibilities included evaluate, critical assessment and selection of innovative pharmaceutical and.

Assessed potential to in-license technologies, including technical probability of success and potential market applications. Co-developed joint ventures and business plan. Managed the day-to-day operations. Presented company to angel and venture capital firms for potential investment.

VC financed by Oxford Bioscience Partners, involved in the in silico discovery and development of first generation, novel disease modifying and disease reversing therapeutics for the treatment of cardiovascular disease.Privately held biopharmaceutical company, venture financed by Oxford Bioscience Partners, involved in the in silico discovery and.

Laboratory Manager, All aspects of preclinical antiretroviral research,Managed all aspects of a cutting edge laboratory facility. Developed method for transcutaneous transfection of Langerhans cells for T cell mediated immunization of murine & non-human primates as a model for SHIV & HIV vaccines. Assisted in all aspects of preclinical, phase one and two.

Vice President of Operations, Co-Founder, Member of the Board of Directors, Treasurer, Tax Matters Partner, Genetic Immunity, LLC, Georgetown University Medical School, Washington, DC. Co-founded a pharmaceutical research and drug development company for the treatment and prevention of viral diseases. Company currently headquartered in Budapest, Hungary..

research programs covering a range of clinical topics including infectious disease, trauma medicine, health maintenance and cancer.; included quantifying the ubiquitin conjugating enzymes in immortalized cell lines through the use of biochemical and molecular techniques, conjugation and degradation of topoisomerase 1 and ubiquitin as influenced by the.

Arlington, Virginia, US

US Army Infantry, 3-64 Armor, Infantry support (11C), AFRC Services Staff

Education record

Bachelors Of Science, Biological Sciences